Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel

Circulation. 1998 Feb 24;97(7):640-4. doi: 10.1161/01.cir.97.7.640.

Abstract

Background: A heritable form of the long-QT syndrome (LQT3) has been linked to mutations in the cardiac sodium channel gene (SCN5A). Recently, a sporadic SCN5A mutation was identified in a Japanese girl afflicted with the long-QT syndrome. In contrast to the heritable mutations, this externally positioned domain IV, S4 mutation (R1623Q) neutralized a charged residue that is critically involved in activation-inactivation coupling.

Methods and results: We have characterized the R1623Q mutation in the human cardiac sodium channel (hH1) using both whole-cell and single-channel recordings. In contrast to the autosomal dominant LQT3 mutations, R1623Q increased the probability of long openings and caused early reopenings, producing a threefold prolongation of sodium current decay. Lidocaine restored rapid decay of the R1623Q macroscopic current.

Conclusions: The R1623Q mutation produces inactivation gating defects that differ mechanistically from those caused by LQT3 mutations. These findings provide a biophysical explanation for this severe long-QT phenotype and extend our understanding of the mechanistic role of the S4 segment in cardiac sodium channel inactivation gating and class I antiarrhythmic drug action.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Female
  • Genes, Dominant
  • Humans
  • Lidocaine / pharmacology
  • Long QT Syndrome / genetics*
  • Long QT Syndrome / metabolism
  • Mutagenesis, Site-Directed
  • NAV1.5 Voltage-Gated Sodium Channel
  • Oocytes / drug effects
  • Patch-Clamp Techniques
  • Phenotype
  • Point Mutation*
  • Recombinant Fusion Proteins / metabolism
  • Sodium Channels / drug effects
  • Sodium Channels / genetics*
  • Sodium Channels / metabolism
  • Xenopus

Substances

  • Anti-Arrhythmia Agents
  • NAV1.5 Voltage-Gated Sodium Channel
  • Recombinant Fusion Proteins
  • SCN5A protein, human
  • Sodium Channels
  • Lidocaine